ESPR vs UPS · rev $332.3M vs P/E 15, rev $88.66B
Esperion Therapeutics Inc (ESPR) versus United Parcel Service Inc (UPS) — a side-by-side from cached financials, not a winner call.
Esperion Therapeutics Inc (ESPR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
United Parcel Service Inc (UPS) is a integrated freight & logistics company listed on US.
Latest reported ESPR revenue for 2024-12-31 was $332.3M. Net income was -$51.7M. Revenue was up 185.7% from 2023-12-31 to 2024-12-31. ESPR currently screens at market cap $816.9M.
Latest reported UPS revenue for 2025-12-31 was $88.66B. Net income was $5.57B. Revenue was down 2.6% from 2024-12-31 to 2025-12-31. UPS currently screens at market cap $85.76B and trailing P/E 14.8.
ESPR currently screens at market cap $816.9M. UPS currently screens at market cap $85.76B and trailing P/E 14.8.
Not investment advice. Open the ESPR and UPS stock pages for the full models.
Not investment advice.